Initially developed for the HIV/AIDS crisis in 1992, the US Food and Drug Administration (FDA) established the accelerated approval program to expedite the approval of …
Highlights of a recent panel debate moderated by Christian K Schneider, head of Biopharma Excellence, reviewing emerging approaches to clinical data collection where patient populations …
The highly regulated nature of the pharmaceutical industry means that organisations within this sector are no strangers to the requirement to abide by the various …
Amplexor asked some of its closest partners for their views on the most important developments in Life Sciences regulatory operations in 2022, and for their …
Biopharmaceutical companies are now at an important inflexion point. Most have completed their modernisation of the Regulatory function globally, bringing improvements to efficiency, according to …
Initially developed for the HIV/AIDS crisis in 1992, the US Food and Drug Administration (FDA) established the accelerated approval program to expedite the approval of drugs for serious …
Highlights of a recent panel debate moderated by Christian K Schneider, head of Biopharma Excellence, reviewing emerging approaches to clinical data collection where patient populations are small. Biopharma …
The highly regulated nature of the pharmaceutical industry means that organisations within this sector are no strangers to the requirement to abide by the various strict rules and …
Amplexor asked some of its closest partners for their views on the most important developments in Life Sciences regulatory operations in 2022, and for their predictions for 2023. …
Biopharmaceutical companies are now at an important inflexion point. Most have completed their modernisation of the Regulatory function globally, bringing improvements to efficiency, according to newly-published Gens & …
Despite the recent shift to hybrid and decentralised clinical trials (DCT), low enrolment, poor retention, and outdated processes are still holding research back. But it’s not the technology …
Catalyst is a clinical research organization (CRO) that provides highly customizable solutions to the global biopharmaceutical industry through two established, branded solutions: Catalyst Oncology and Catalyst Flex The company …
PCI is a leading global CDMO, truly spanning the cycle, connecting development and commercialization, de-risking the supply chain providing clients with integrated end-to-end drug development, …
Tower Cold Chain is a leading provider of temperature-controlled solutions to the global pharmaceutical, biotech and life-science industries. Working with businesses since 2007 to protect …
Ramus Corporate Group is a union between Ramus Medical and Medical Diagnostic Laboratory Ramus. Ramus Medical is a full service Contract Research Organization based in …
Meet the Masters of Medical Writing At Trilogy, medical writing is our passion. As specialists in regulatory documentation, we provide a service that is more …
SGS, LIFE SCIENCES – CLINICAL RESEARCH SGS is a leading life sciences CRO providing clinical research and bioanalytical testing with a specific focus on early …
Journal For Clinical Studies has a distinguished editorial advisory board providing the best guidelines for global clinical trials. Your resource for Multisite Studies and emerging markets.
